Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q2 2024 · 10-Q
Revenue$1.38M$1.38M+195.4% vs Q2 2023 Net Income-$2.86M-$2.86MN/M vs Q2 2023 EPS Diluted-$0.11-$0.11N/M vs Q2 2023 Gross Profit$390,419+1,139.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,175,163N/M Free Cash Flowderived-$2,206,523N/M Margins · derivedGross margin28.3%+21.6 pt vs Q2 2023
Operating margin-209.5%+540.4 pt vs Q2 2023
Net margin-207.3%+548.4 pt vs Q2 2023
ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end